Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,934.00
Bid: 1,933.00
Ask: 1,935.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,938.00
High: 1,942.00
Low: 1,926.00
Prev. Close: 1,935.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 14th Feb 2013 08:09

African Barrick Gold: Deutsche Bank cuts target price from 410p to 340p, while staying with its hold recommendation. Investec reduces target price from 405p to 315p and downgrades from buy to hold. JP Morgan lowers target price from 370p to 290p and downgrades to underweight.AG Barr: Barclays downgrades to equal-weight. Canaccord Genuity downgrades to hold with a target price of 490p.ASOS: HSBC raises target price from 2750p to 3530p and upgrades to overweight.Barclays: Deutsche Bank revises target price from 360p to 380p maintaining a buy recommendation. Investec moves target price from 320p to 340p, while downgrading from buy to hold.Brown (N) Group: HSBC takes target price from 420p to 430p reiterating an overweight rating.Britvic: Barclays cuts to equal-weight. JP Morgan lowers target price from 400p to 380p and downgrades to underperform.Daily Mail and General Trust: UBS raises target price from 520p to 650p maintaining a neutral rating.Euromoney Institutional Investor: UBS increases target price from 775p to 900p and retains a neutral rating.FlyBe: HSBC lowers target price from 80p to 70p and retains an overweight rating.Gulfsands Petroleum: Cantor Fitzgerald (formerly Seymour Pierce) reduces target price from 366p to 162p and keeps a buy recommendation.G4S: Investec revises target price from 280p to 330p and upgrades from hold to buy.Halma: Investec increases target price from 515p to 550p keeping a buy recommendation.Hikma: Panmure Gordon ups target price from 825p to 930p, while leaving its buy recommendation unchanged.JSC Bank of Georgia Holdings: Citigroup downgrades to neutral with a target price of 1500p.Laird: JP Morgan moves target price from 281p to 291p reiterating an overweight rating. Numis increases target price from 250p to 310p and stays with its buy recommendation.McBride: Investec shifts target price from 150p to 154p and maintains a buy rating.Morgan Crucible: Investec ups target price from 295p to 370p and leaves its buy recommendation unchanged.Newmark Security: Cantor Fitzgerald (formerly Seymour Pierce) moves target price from 1.50p to 2.00p maintaining a buy recommendation.Next: HSBC increases target price from 4100p to 4965p upgrading to overweight.Norcros: Numis downgrades to add with a target price of 20p.Oxford Instruments: JP Morgan takes target price from 1500p to 1750p and leaves its overweight rating unchanged.Reckitt Benckiser: Deutsche Bank ups target price from 4600p to 4800p and stays with its buy recommendation. Credit Suisse raises target price from 3700p to 4000p retaining a neutral rating. Nomura increases target price from 4800p to 4900p, while its buy recommendation is kept. Oriel Securities moves target price from 3730p to 4700p upgrading to add.Rolls-Royce Group: Investec downgrades from buy to add with its target price at 1005p.Salamander Energy: Investec revises target price from 200p to 250p and upgrades from hold to buy.SOCO International: Exane BNP lowers target price from 405p to 390p, while leaving its neutral rating unaltered.Spirent Communications: Panmure Gordon shifts target price from 184p to 192p and keeps a buy recommendation.SVG Capital: Oriel Securities shifts target price from 360p to 370p, while its buy recommendation is kept.Synergy Health: Investec raises target price from 1048p to 1105p, while downgrading from buy to add.Telecity Group: Investec ups target price from 750p to 1000p and upgrades from hold to buy. UBS revises target price from 945p to 1000p reiterating a buy recommendation.Tullow Oil: Deutsche Bank reduces target price from 1105p to 1075p keeping a hold recommendation. Credit Suisse cuts target price from 1450p to 1350p, while its neutral rating remains unchanged. Nomura lowers target price from 1350p to 1330p and retains a reduce rating.Whitbread: Investec increases target price from 1650p to 2000p, but still recommends selling.
More News
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.